Peripheral blood mononuclear cells
In one sentence
Peripheral blood mononuclear cells are the circulating white blood cells with a single, unsegmented nucleus, mainly lymphocytes and monocytes, that can be isolated for immune assays.
The intuition
Think of a blood sample as a mixed crowd. Preparing peripheral blood mononuclear cells (PBMCs) selects one part of that crowd for further study. It gives researchers a useful working collection, not a miniature version of the whole immune system.
The analogy breaks at location and selection. Cells recovered from blood do not represent every cell in a tumor or lymph node. Even the recovered blood mixture depends on how it was collected and processed.
How it works
PBMCs include T cells, B cells, natural killer (NK) cells, monocytes and smaller populations. “Mononuclear” describes the nucleus, not a single cell type or shared function. Most conventional granulocytes, such as neutrophils, are outside this category.
A common preparation layers anticoagulated blood over a density-separation medium and centrifuges it. Mononuclear cells accumulate in an interface that can be collected and washed. Red cells and many granulocytes separate elsewhere. Recovery is incomplete; platelets, red cells or low-density granulocytes can contaminate a preparation. The label PBMC therefore does not guarantee purity.
The laboratory counts cells, measures viability and allocates aliquots. Cells may be used fresh or frozen under a validated cryopreservation procedure. Thawing, washing and any resting step can change the recovered mixture. A high viability percentage alone does not prove that all populations or functions were preserved.
Preparing PBMCs is a sample-processing step. Flow cytometry, intracellular cytokine staining and enzyme-linked immunospot (ELISpot) then ask different questions of that material.
Why it matters in cancer
Repeated blood sampling can support immune monitoring without repeatedly obtaining tumor tissue. But blood and tumor are different compartments. A blood response may not reach the cancer; an important tumor-localized response may be missed in blood.
Handling is part of the evidence. Comparing a rapidly processed baseline sample with a delayed follow-up sample can confound a biological comparison. Cell banking also preserves material only to the extent supported by the collection, storage and downstream assay validation.
Preparation card
| Field | What to record |
|---|---|
| Input and tissue cost | Anticoagulated blood or an appropriate blood-cell collection product; separation consumes that aliquot. Available viable cells, rather than blood volume alone, limit downstream tests. |
| Output and units | Recovered cell number, viable-cell percentage, recovery after thawing and measured population fractions; cells per original blood volume require a documented calculation. |
| Controls | Collection and processing timestamps, anticoagulant, storage conditions, counting and viability methods, contamination checks and matched handling across time points. |
| Thresholds | Acceptance rules established for the intended downstream assay, not one universal PBMC-quality number. |
| Failure modes | Delay, poor separation, contamination, selective cell loss, freezing or thawing injury and insufficient cells for rare responses. |
| What it cannot tell you | Tumor infiltration, immune function, receptor specificity or whether stored cells are suitable for every future assay or treatment. |
| Validation context | The preparation and downstream assay must be assessed together. A handling protocol validated for one stimulus or study cannot automatically be transferred to another. |
Worked example
In a fictional study, two tubes yield equally high viable-cell percentages. One has far fewer recovered monocytes. Are they interchangeable for a whole-protein stimulation assay?
Answer: Not automatically. Monocytes can contribute antigen presentation, and selective loss may change the response. Check composition, recovery and assay performance, not viability alone.
Common confusions
- PBMCs are not all blood cells: red cells and most granulocytes are not the intended fraction.
- Isolation is not purification of T cells: the fraction contains several immune populations.
- Blood sampling is not tumor sampling: repertoire overlap does not erase the compartment difference.
- Freezing is not guaranteed preservation: suitability depends on the cells, handling and intended use.
Related concepts
Sources and scope
Source-checked October 9, 2026. Sample preparation, not a personal collection or banking recommendation; expert and learner review pending.
- Böyum, 1968: isolation of mononuclear cells and granulocytes from human blood. Foundational primary separation method.
- Bull et al., 2007: blood-processing parameters for cryopreserved antigen-specific responses. Primary HIV-vaccine assay study; establishes handling sensitivity in its tested protocols, not a universal cancer-assay schedule.
- Cossarizza et al., 2021: flow cytometry guidelines, third edition. Methods guidance on preparation, viability and analysis.